Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes

被引：0
|
作者：
Hong-wei Gao
Chao Xie
Hai-ning Wang
Yu-jing Lin
Tian-pei Hong
机构：
[1] Peking University Third Hospital,Department of Endocrinology
来源：
Acta Pharmacologica Sinica | 2007年 / 28卷
关键词：
nateglinide; acarbose; free fatty acids; asymmetric dimethylarginine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：534 / 539
页数：5
相关论文
共 50 条
  • [21] Efficacy and mechanism of insulin secretagogues and acarbose in newly diagnosed type 2 diabetes
    Fan, Shizhen
    Ma, Jianxin
    Ma, Meiling
    Niu, Ruifang
    Ma, Yuehua
    Zhao, Zhigang
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 : 4 - 5
  • [22] Periodontal Tissue Status in Patients with Newly-Diagnosed and Treated Type 2 Diabetes - Comparative Analysis
    Wyszynska, Malgorzata
    Napora, Magdalena
    Grabowska, Ewa
    Kaluza, Bernadetta
    Franek, Edward
    Gorska, Renata
    DENTAL AND MEDICAL PROBLEMS, 2016, 53 (04) : 459 - 467
  • [23] Comparison of the acute effects of nateglinide versus glibenclamide on postprandial metabolic control in type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, I
    Samartzis, A
    Raptis, SA
    DIABETES, 2002, 51 : A95 - A95
  • [24] PERIPHERAL AUTONOMIC IMPAIRMENT IN PATIENTS NEWLY-DIAGNOSED WITH TYPE-II DIABETES
    MCDAID, EA
    MONAGHAN, B
    PARKER, AI
    HAYES, JR
    ALLEN, JA
    DIABETES CARE, 1994, 17 (12) : 1422 - 1427
  • [25] Immunological markers of diabetes in newly-diagnosed Tunisian patients
    Harzallah, F.
    Haouat, E.
    Ben Brahim, A.
    Laadhar, L.
    Zitouni, M.
    Makni, S.
    Slimane, H.
    DIABETES & METABOLISM, 2008, 34 : A51 - A51
  • [26] Weight change patterns and healthcare costs in patients with newly-diagnosed type-2 diabetes in Sweden
    Sabale, Ugne
    Bodegard, Johan
    Svennblad, Bodil
    Ostgren, Carl Johan
    Johansson, Gunnar
    Ekman, Mattias
    Henriksson, Martin
    Nilsson, Peter
    PRIMARY CARE DIABETES, 2017, 11 (03) : 217 - 225
  • [27] Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetes
    Lian, Hong
    Ren, Qian
    Liu, Wei
    Zhang, Rui
    Zou, Xiantong
    Zhang, Simin
    Luo, Yingying
    Deng, Wei
    Wang, Qiuping
    Qi, Lin
    Li, Yufeng
    Wang, Wenbo
    Zhong, Liyong
    Zhang, Pengkai
    Guo, Chengcheng
    Li, Li
    Li, Yating
    Ba, Tianhao
    Yang, Chaochao
    Huo, Lili
    Wang, Yan'ai
    Li, Chunxia
    Hao, Dejun
    Zhang, Yajing
    Xu, Yan
    Wang, Fang
    Wang, Xiangqing
    Zhang, Fang
    Gong, Siqian
    Yang, Wenjia
    Han, Xueyao
    Ji, Linong
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [28] Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes
    Shimodaira, Masanori
    Niwa, Tomohiro
    Nakajima, Koji
    Kobayashi, Mutsuhiro
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (03) : 223 - 228
  • [29] Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
    Pan, Qingrong
    Xu, Yuan
    Yang, Ning
    Gao, Xia
    Liu, Jia
    Yang, Wenying
    Wang, Guang
    MEDICINE, 2016, 95 (14)
  • [30] MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
    Wang, Na
    Zhang, Jin-Ping
    Xing, Xiao-Yan
    Yang, Zhao-Jun
    Zhang, Bo
    Wang, Xin
    Yang, Wen-Ying
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (02) : 309 - 320
12345